Pure Global

CK-MB CLIA Microparticles - India CDSCO Medical Device Registration

CK-MB CLIA Microparticles is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000395_f53d820ace057080c525c3067f8d19ef_6827e5de93254342f01f608d7d34ac71. This device is marketed under the brand name T4 CLIA Microparticles. The license holder is Matrix Labs, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
CK-MB CLIA Microparticles
UID: IMP/IVD/2019/000395_f53d820ace057080c525c3067f8d19ef_6827e5de93254342f01f608d7d34ac71

Brand Name

T4 CLIA Microparticles

License Holder

Matrix Labs

Device Class

Class B

Approving Authority

CDSCO

Product Information

This assay is based on a chemiluminescent microparticle immunoassay (T4 CLIA Microparticles) for the quantitative determination of Creatine Kinase-MB (T4 CLIA Microparticles) concentration in human serum and plasma (T4 CLIA Microparticles)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing